Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Bierbeek – page 160

1 924 clinical trials in Bierbeek, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Bierbeek at a glance
1 924
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 924 trials in Bierbeek

Open in trial search

Breast cancer

Not recruiting

Study on Amcenestrant Alone and with Drug Combination for Postmenopausal Women with Estrogen Receptor-Positive Advanced Breast Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study Comparing ONC-392 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After PD-1/PD-L1 Inhibitor Treatment

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Oncoc4 Inc.

Study on the Effects of Buspirone Hydrochloride for Patients with Weak or Absent Esophageal Motility

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Buspirone Hydrochloride
  • Sponsor:UZ Leuven

Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Crisantaspase
  • Sponsor:Universita Degli Studi Di Milano Bicocca

Asthma

Not recruiting

Study on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Major depression

Not recruiting

Study on Aticaprant for Adults with Major Depressive Disorder and Anhedonia Not Responding to Antidepressants

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Aticaprant
  • Sponsor:Janssen Cilag International

Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Gilead Sciences Inc.

Alveolar proteinosis

Not recruiting

Study of Inhaled Molgramostim for Adults with Autoimmune Pulmonary Alveolar Proteinosis

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Molgramostim
  • Sponsor:Savara ApS

Crohn's disease

Not recruiting

Study of AZD7798 compared to placebo in patients with moderate to severe Crohn's disease

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:AZD7798
  • Sponsor:AstraZeneca AB

Merycism

Not recruiting

Study on Clebopride for Treating Rumination Syndrome in Patients Suspected of Having the Condition

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Clebopride Hydrogen Maleate
  • Sponsor:UZ Leuven

Study on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Ibrutinib
  • Sponsor:Klinikum Der Universitat Munchen AöR

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Bierbeek

What the registry says about research in the country

01 Mental Health Research

Ongoing clinical investigations focusing on schizophrenia and cognitive impairment, evaluating long-term safety profiles of innovative therapeutic approaches.

  • Cognitive Function Assessment
  • Treatment Safety Evaluation
  • Extended Care Studies

This research builds upon previous clinical trials, specifically examining the continued effectiveness and safety of iclepertin in patients who have completed earlier treatment phases.

02 Psychiatric Therapeutics

Advanced research in psychiatric treatment focusing on developing safer, more effective therapies for individuals with chronic mental health conditions.

  • Long-term Safety Monitoring
  • Patient Follow-up Studies
  • Treatment Efficacy Assessment

The studies aim to enhance understanding of long-term therapeutic outcomes in patients with cognitive impairment related to schizophrenia.

03 Cognitive Health Studies

Comprehensive research examining the intersection of cognitive function and mental health conditions, with a focus on therapeutic interventions.

  • Cognitive Performance Evaluation
  • Extended Treatment Benefits
  • Safety Profile Analysis

These trials represent continued efforts to improve treatment options for individuals affected by cognitive challenges associated with psychiatric conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.